MetaCap

Ascentage Pharma Group International American Depository Shares (AAPG)

NASDAQ: AAPGHealth CareBiotechnology: Pharmaceutical PreparationsUSD

11.97-0.47 (-3.78%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

AAPG stock chart

Technical analysis

Key statistics

All statistics
EPS (TTM)
-$2.26
52-week range
11.97 – 33.09
Day range
11.97 – 12.13
Volume / Avg
5.04K / 6.97K
Beta
—

52-week range

$11.97$33.09

AAPG stock today

Ascentage Pharma Group International American Depository Shares (AAPG) closed at $11.97 on Nov 20, down 3.78% (-$0.47), versus the S&P 500's 3.70% decline. Shares are 63.8% below their 52-week high of $33.09, set on Dec 2, 2025 and 0.0% above the 52-week low of $11.97, near the bottom of the past year's range. AAPG is down 54.4% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 60.9%.

Ascentage Pharma Group International American Depository Shares has posted a net loss over the last twelve months (EPS of -$2.26), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Ascentage Pharma Group International American Depository Shares

Company profile

Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company's primary product candidate is HQP1351, a BCR-ABL inhibitor targeting BCR-ABL1 mutants, including those with the T315I mutation. It also develops APG-2575, an oral administered Bcl-2 selective inhibitor for hematologic malignancies and solid tumors; APG-115, an oral small molecule inhibitor of the MDM2-p53 protein-protein interactions to treat solid tumors and hematological malignancies; and APG-1252, a small molecule drug to restore apoptosis through dual inhibition of the Bcl-2 and Bcl-xL proteins for the treatment of small-cell lung cancer, non-small cell lung cancer, neuroendocrine tumor, and non-Hodgkin's lymphoma.

Industry
Biotechnology: Pharmaceutical Preparations
CEO
Dr. Dajun Yang M.D., Ph.D.
Headquarters
Suzhou
Employees
828
IPO year
2025

Financial highlights

Full financials

In fiscal 2024, Ascentage Pharma Group International American Depository Shares generated $134.3 million in revenue. Ascentage Pharma Group International American Depository Shares reported a net loss of $55.5 million. Gross margin was 97.0%.

Ascentage Pharma Group International American Depository Shares annual revenue, net income and EPS
Fiscal yearFY 2024
Revenue$134.35M
Growth—
Net income$-55.54M
EPS (diluted)$-0.18

Analyst forecast

Forecast

Consensus (11 analysts)

strong_buy

Avg. price target

$44.50+271.76%

  • Strong buy 3
  • Buy 8
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $33.00High $55.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

AAPG news

All AAPG news

Ascentage Pharma Group International American Depository Shares peers

Health Care sector
AAPG peer companies
CompanyPrice% ChgMarket capCompare
CMPSCOMPASS Pathways Plc American Depository Shares8.05-6.94%$1.14Bvs AAPG
HROWHarrow Inc.30.41-5.35%$1.14Bvs AAPG
KARDKardigan Inc.11.54-7.83%$1.08Bvs AAPG
GPCRStructure Therapeutics Inc. ADR16.13-5.78%$1.15Bvs AAPG
OPKOPKO Health Inc.1.57-2.48%$1.17Bvs AAPG
JBIOJade Biosciences Inc.15.31+1.66%$1.06Bvs AAPG
NKTRNektar Therapeutics30.20-7.19%$1.03Bvs AAPG
CTYCity Therapeutics Inc.19.32+5.29%$1.03Bvs AAPG

Indexes, lists and sector

Ascentage Pharma Group International American Depository Shares stock FAQ

What is Ascentage Pharma Group International American Depository Shares's stock price today?

AAPG last traded at $11.97 as of Nov 20, 4:00 PM EST, down 3.78% on the day. Prices are delayed at least 15 minutes.

Who is Ascentage Pharma Group International American Depository Shares's CEO?

Dr. Dajun Yang M.D., Ph.D. is the chief executive officer of Ascentage Pharma Group International American Depository Shares, which has about 828 employees.

What is the AAPG 52-week high?

The 52-week high for AAPG is $33.09 and the 52-week low is $11.97. The stock is currently 63.8% below its high.

Compare AAPG